The needs of surveillance of metabolic associated fatty liver disease in Taiwan

被引:0
|
作者
Cheng, Pin-Nan [1 ]
机构
[1] Natl Cheng Kung Univ, Dept Internal Med, Natl Cheng Kung Univ Hosp, Coll Med, Tainan, Taiwan
关键词
HEPATOCELLULAR-CARCINOMA; MORTALITY; NAFLD;
D O I
10.1002/aid2.13285
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
下载
收藏
页码:71 / 72
页数:2
相关论文
共 50 条
  • [21] Dietary patterns associated with metabolic associated fatty liver disease protection
    Schophaus, Simon
    Creasy, Kate Townsend
    Clusmann, Jan
    Koch, Alexander
    Trautwein, Christian
    Schneider, Kai Markus
    Schneider, Carolin Victoria
    JOURNAL OF HEPATOLOGY, 2023, 78 : S636 - S636
  • [22] Molecular characterization of metabolic associated fatty liver disease as an immune-mediated inflammatory disease: IMID associated fatty liver disease
    Garcia-Nieto, Enrique
    Carlos Rodriguez-Duque, Juan
    Iruzubieta, Paula
    Garcia-Blanco, Agustin
    Rivas, Coral
    Luisa Cagigal, Maria
    Rueda-Gotor, Javier
    Rivero, Montserrat
    Armesto, Susana
    Antonio Gonzalez-Lopez, Marcos
    Duran-Vian, Carlos
    Esteve Codina, Anna
    Gut, Marta
    Pedro Vaque, Jose
    Crespo, Javier
    Arias Loste, Maria Teresa
    JOURNAL OF HEPATOLOGY, 2022, 77 : S113 - S113
  • [23] Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Zhang, Pengwei
    Dong, Xianhui
    Zhang, Wei
    Wang, Shiyin
    Chen, Chen
    Tang, Jiake
    You, Yao
    Hu, Siqi
    Zhang, Shenghui
    Wang, Chunyi
    Wen, Wen
    Zhou, Mengyun
    Tan, Tao
    Qi, Guanming
    Li, Li
    Wang, Mingwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (01)
  • [24] Metabolic-associated fatty liver disease (MAFLD) in coeliac disease
    Rispo, Antonio
    Imperatore, Nicola
    Guarino, Maria
    Tortora, Raffaella
    Alisi, Anna
    Cossiga, Valentina
    Testa, Anna
    Ricciolino, Simona
    Fiorentino, Andrea
    Morisco, Filomena
    LIVER INTERNATIONAL, 2021, 41 (04) : 788 - 798
  • [25] Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease
    Danielsson, Oscar
    Vesterinen, Tiina
    Arola, Johanna
    Aberg, Fredrik
    Nissinen, Markku J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (07) : 961 - 969
  • [26] Prevalence and Impact of Fatty Liver Disease in Adult Deceased Liver Transplant Donors: Metabolic-Associated Fatty Liver Disease or Nonalcoholic Fatty Liver Disease?
    Liu, Ken
    Pandya, Keval
    West, Claire
    Virtue, Susan
    McCaughan, Geoffrey W.
    LIVER TRANSPLANTATION, 2021, 27 (10) : 1498 - 1501
  • [27] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [28] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    Diabetology & Metabolic Syndrome, 14
  • [29] Prevalence and associated metabolic factors of fatty liver disease in the elderly
    Wang, Zhongli
    Xu, Ming
    Peng, Jianhong
    Jiang, Li
    Hu, Zhengguo
    Wang, Hua
    Zhou, Shiqing
    Zhou, Rui
    Hultstrom, Michael
    Lai, En Yin
    EXPERIMENTAL GERONTOLOGY, 2013, 48 (08) : 705 - 709
  • [30] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123